Profile data is unavailable for this security.
About the company
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
- Revenue in USD (TTM)109.24bn
- Net income in USD1.99bn
- Incorporated1964
- Employees67.60k
- LocationHumana Inc500 W Main StLOUISVILLE 40202United StatesUSA
- Phone+1 (502) 580-1000
- Fax+1 (302) 655-5049
- Websitehttps://www.humana.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Corp | 4.96bn | 386.50m | 8.70bn | 22.36k | 22.73 | 4.99 | 11.14 | 1.75 | 3.80 | 3.68 | 48.76 | 17.30 | 0.8276 | -- | 8.74 | 221,721.20 | 8.36 | 6.37 | 10.58 | 7.94 | 95.50 | 95.58 | 10.10 | 9.16 | -- | 5.59 | 0.5298 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Solventum Corp | 8.20bn | 1.29bn | 10.25bn | 22.01k | 7.93 | 2.66 | 5.55 | 1.25 | 7.48 | 7.48 | 47.54 | 22.30 | -- | -- | -- | 372,699.60 | -- | -- | -- | -- | 57.64 | -- | 15.73 | -- | 1.33 | 43.79 | 0.6832 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
| Universal Health Services, Inc. | 14.66bn | 816.29m | 12.58bn | 73.35k | 16.09 | 2.03 | 9.05 | 0.8579 | 11.79 | 11.79 | 211.29 | 93.48 | 1.06 | -- | 6.77 | 199,837.00 | 5.96 | 6.44 | 6.98 | 7.63 | -- | -- | 5.61 | 6.55 | 1.28 | 6.16 | 0.4352 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.34bn | 815.64m | 12.90bn | 70.00k | 16.71 | 13.93 | 6.99 | 1.05 | 8.81 | 8.81 | 133.10 | 10.56 | 0.7224 | 66.04 | 5.30 | 176,257.20 | 6.40 | 5.62 | 8.50 | 7.45 | 32.40 | 30.70 | 8.85 | 8.33 | 1.37 | 5.01 | 0.7759 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Tenet Healthcare Corp | 20.90bn | 2.62bn | 13.21bn | 78.14k | 5.23 | 3.82 | 3.14 | 0.6322 | 25.87 | 25.87 | 201.91 | 35.35 | 0.7466 | 9.04 | 6.50 | 267,391.00 | 11.97 | 3.61 | 17.38 | 5.09 | 82.64 | 82.97 | 16.03 | 4.95 | 1.37 | 4.49 | 0.6267 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Quest Diagnostics Inc | 9.29bn | 842.00m | 15.77bn | 40.00k | 19.10 | 2.45 | 11.97 | 1.70 | 7.43 | 7.43 | 82.00 | 57.95 | 0.6944 | 33.57 | 7.21 | 232,175.00 | 6.51 | 9.28 | 7.61 | 10.81 | 32.95 | 36.64 | 9.37 | 12.97 | 0.8908 | 8.40 | 0.4184 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Labcorp Holdings Inc | 12.30bn | 399.20m | 16.43bn | 67.00k | 42.67 | 2.06 | 17.00 | 1.34 | 4.57 | 4.95 | 142.45 | 94.42 | 0.6698 | 18.59 | 4.68 | 183,588.10 | 2.18 | 6.27 | 2.68 | 7.37 | 27.74 | 32.33 | 3.25 | 9.51 | 0.7564 | 5.95 | 0.3934 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Molina Healthcare Inc | 35.85bn | 1.07bn | 18.43bn | 18.00k | 17.06 | 4.13 | 14.83 | 0.5142 | 18.43 | 18.43 | 617.11 | 76.15 | 2.48 | -- | 12.18 | 1,991,889.00 | 7.42 | 7.62 | 16.79 | 16.80 | 15.74 | 15.99 | 2.99 | 3.04 | -- | 14.69 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
| Centene Corp | 155.52bn | 2.74bn | 38.20bn | 67.70k | 14.22 | 1.42 | 9.54 | 0.2457 | 5.03 | 5.03 | 287.04 | 50.26 | 1.88 | -- | 9.71 | 2,297,149.00 | 3.29 | 2.58 | 5.47 | 3.99 | 11.18 | 11.59 | 1.75 | 1.37 | -- | 4.56 | 0.3994 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 109.24bn | 1.99bn | 43.15bn | 67.60k | 22.29 | 2.68 | 14.40 | 0.395 | 16.07 | 16.07 | 886.68 | 133.86 | 2.08 | -- | -- | 1,616,021.00 | 3.92 | 7.57 | -- | -- | -- | -- | 1.88 | 3.35 | -- | 7.72 | 0.4494 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| HCA Healthcare Inc | 66.72bn | 5.47bn | 88.99bn | 220.00k | 16.93 | -- | 9.40 | 1.33 | 20.07 | 20.07 | 244.21 | -6.14 | 1.22 | 5.09 | 7.14 | 303,254.50 | 11.58 | 11.99 | 15.90 | 15.75 | 84.79 | 84.10 | 9.52 | 10.17 | 1.02 | 5.05 | 0.9694 | 10.54 | 7.86 | 6.84 | -7.11 | 10.13 | 5.83 | 11.38 |
| Cigna Group | 206.00bn | 3.62bn | 97.90bn | 72.50k | 28.29 | 2.38 | 14.23 | 0.4752 | 12.18 | 12.18 | 701.28 | 144.90 | 1.37 | 40.82 | 10.77 | 2,841,421.00 | 2.56 | 4.09 | 3.78 | 5.55 | 12.40 | 13.98 | 1.87 | 3.61 | 0.7451 | 2.85 | 0.4421 | 13.69 | 8.17 | 32.15 | -22.97 | 14.42 | 24.40 | 161.81 |
Data as of Jun 01 2024. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD
33.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 10.54m | 8.75% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.24m | 5.18% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 5.61m | 4.66% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 5.49m | 4.56% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 2.52m | 2.09% |
| Geode Capital Management LLCas of 31 Mar 2024 | 2.46m | 2.04% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 2.23m | 1.85% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 2.14m | 1.78% |
| Davis Selected Advisers LPas of 31 Mar 2024 | 1.99m | 1.65% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.48m | 1.23% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
